Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-2-10
pubmed:abstractText
End-stage congestive heart failure (CHF) is associated with a high mortality rate and is often refractory to standard medical treatment. Although parenteral inotropes have been beneficial in hospitalized patients, their use in outpatients has been limited by toxicity and tachyphylaxis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0002-8703
pubmed:author
pubmed:issnType
Print
pubmed:volume
135
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
121-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9453531-Adult, pubmed-meshheading:9453531-Aged, pubmed-meshheading:9453531-Aged, 80 and over, pubmed-meshheading:9453531-Cardiomyopathy, Dilated, pubmed-meshheading:9453531-Cardiotonic Agents, pubmed-meshheading:9453531-Drug Administration Schedule, pubmed-meshheading:9453531-Female, pubmed-meshheading:9453531-Heart Failure, pubmed-meshheading:9453531-Hemodynamics, pubmed-meshheading:9453531-Home Nursing, pubmed-meshheading:9453531-Humans, pubmed-meshheading:9453531-Infusion Pumps, pubmed-meshheading:9453531-Male, pubmed-meshheading:9453531-Middle Aged, pubmed-meshheading:9453531-Milrinone, pubmed-meshheading:9453531-Pilot Projects, pubmed-meshheading:9453531-Pyridones, pubmed-meshheading:9453531-Quality of Life, pubmed-meshheading:9453531-Treatment Outcome, pubmed-meshheading:9453531-Vasodilator Agents
pubmed:year
1998
pubmed:articleTitle
Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
pubmed:affiliation
Division of Cardiology, Veterans Affairs Medical Center, and University of California, San Diego, USA.
pubmed:publicationType
Journal Article